title: [2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis].
abstract: OBJECTIVE
  Due to increasing improvement in the diagnosis, evaluation and management of osteoporosis and the development of new tools and drugs, the Spanish Society of Rheumatology (SER) has promoted the development of recommendations based on the best evidence available. These recommendations should be a reference to rheumatologists and other health professionals involved in the treatment of patients with osteoporosis.
  
  
  METHODS
  Recommendations were developed following a nominal group methodology and based on a systematic review. The level of evidence and degree of recommendation were classified according to the model proposed by the Center for Evidence Based Medicine at Oxford. The level of agreement was established through Delphi technique. Evidence from previous consensus and available clinical guidelines was used.
  
  
  RESULTS
  We have produced recommendations on diagnosis, evaluation and management of osteoporosis. These recommendations include the glucocorticoid-induced osteoporosis, premenopausal and male osteoporosis.
  
  
  CONCLUSIONS
  We present the SER recommendations related to the biologic therapy risk management.
authors.affiliation: Servicio de Reumatología, Hospital del Mar, Barcelona, España.
authors.forename: Lluís
authors.initials: L
authors.lastname: Pérez Edo
authors.forename: Alberto
authors.initials: A
authors.lastname: Alonso Ruiz
authors.forename: Daniel
authors.initials: D
authors.lastname: Roig Vilaseca
authors.forename: Alberto
authors.initials: A
authors.lastname: García Vadillo
authors.forename: Nuria
authors.initials: N
authors.lastname: Guañabens Gay
authors.forename: Pilar
authors.initials: P
authors.lastname: Peris
authors.forename: Antonio
authors.initials: A
authors.lastname: Torrijos Eslava
authors.forename: Chesús
authors.initials: C
authors.lastname: Beltrán Audera
authors.forename: Jordi
authors.initials: J
authors.lastname: Fiter Aresté
authors.forename: Luis
authors.initials: L
authors.lastname: Arboleya Rodríguez
authors.forename: Jenaro
authors.initials: J
authors.lastname: Graña Gil
authors.forename: Jordi
authors.initials: J
authors.lastname: Carbonell Abelló
authors.forename: Joan Miquel
authors.initials: JM
authors.lastname: Nolla
authors.forename: Susana
authors.initials: S
authors.lastname: Holgado Pérez
authors.forename: Esteban
authors.initials: E
authors.lastname: Salas Heredia
authors.forename: Jaime
authors.initials: J
authors.lastname: Zubieta Tabernero
authors.forename: Javier
authors.initials: J
authors.lastname: Del Pino Montes
authors.forename: Josep
authors.initials: J
authors.lastname: Blanch i Rubió
authors.forename: Manuel
authors.initials: M
authors.lastname: Caamaño Freire
authors.forename: Manuel
authors.initials: M
authors.lastname: Rodríguez Pérez
authors.forename: Santos
authors.initials: S
authors.lastname: Castañeda
authors.forename: Dacia
authors.initials: D
authors.lastname: Cerdá
authors.forename: Carmen
authors.initials: C
authors.lastname: Gómez Vaquero
authors.forename: Javier
authors.initials: J
authors.lastname: Calvo Catalá
authors.forename: Manel
authors.initials: M
authors.lastname: Ciria
authors.forename: Estíbaliz
authors.initials: E
authors.lastname: Loza
mesh_terms: D015502:Absorptiometry, Photon; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D058866:Osteoporotic Fractures / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D012307:Risk Factors; D013030:Spain
chemical_list: D050071:Bone Density Conservation Agents